Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Saved in:
Bibliographic Details
Title: Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Authors: Diamond B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Baughn L; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Poorebrahim M; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Poos AM; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Lee H; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Kaddoura M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Wiedmeier-Nutor JE; Department of Medicine, Mayo Clinic, Phoenix, AZ., Durante M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Otteson G; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Jevremovic D; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Tang H; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany.; Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg, a partnership between German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Medical Oncology, German Cancer Consortium, Heidelberg, Germany.; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Baertsch MA; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Papadimitriou M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Ziccheddu B; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Jelinek T; Department of Hematooncology, Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic., Lemoine C; Department of eBiology, Large Molecule Research, Sanofi R&D, Vitry-sur-Seine, France., Rak A; Department of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, Vitry-sur-Seine, France., Green DJ; Transplantation and Cellular Therapy Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Landgren O; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Neri P; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Bergsagel L; Department of Medicine, Mayo Clinic, Phoenix, AZ., Braggio E; Department of Medicine, Mayo Clinic, Phoenix, AZ., Kumar S; Department of Medicine, Mayo Clinic, Rochester, MN., Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Fonseca R; Department of Medicine, Mayo Clinic, Phoenix, AZ., Bahlis N; Department of Oncology, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Weinhold N; Heidelberg Myeloma Center, Department of Internal Medicine V, Medical Faculty, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University, and German Cancer Research Center, Heidelberg, Germany., Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Blood [Blood] 2025 Sep 25; Vol. 146 (13), pp. 1575-1585.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2024028107